Bénédicte Delcoigne (Benedicte Delcoigne)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 30

Top Venues

RMD open

ACR open rheumatology

Annals of the rheumatic diseases

Rheumatology (Oxford, England)

Karolinska Institutet (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Karolinska Institutet Oct 02 2013

Sweden

PHD :: Medical Epidemiology and Biostatistics

Publications

Bénédicte Delcoigne, AnnaCarin Horne, Johan Reutfors, Johan Askling
Risk of Psychiatric Disorders in Juvenile Idiopathic Arthritis: Population- and Sibling-Controlled Cohort and Cross-Sectional Analyses. ACR open rheumatology 5 (5) (2023)
Hannah Bower, Thomas Frisell, Daniela di Giuseppe, Bénédicte Delcoigne, Johan Askling
Comparative cardiovascular safety with janus kinase inhibitors and biological disease-modifying antirheumatic drugs as used in clinical practice: an observational cohort study from Sweden in patients with rheumatoid arthritis. RMD open 9 (4) (2023)
Liselotte Tidblad, Helga Westerlind, Bénédicte Delcoigne, Johan Askling, Saedis Saevarsdottir
Comorbidities and chance of remission in patients with early rheumatoid arthritis receiving methotrexate as first-line therapy: a Swedish observational nationwide study. RMD open 9 (4) (2023)
Bénédicte Delcoigne, Tine Iskov Kopp, Elizabeth V Arkema, Karin Hellgren, Sella Aarrestad Provan, Heikki Relas, Kalle Aaltonen, Nina Trokovic, Bjorn Gudbjornsson, Gerdur Grondal, Eirik Klami Kristianslund, Jesper Lindhardsen, Lene Dreyer, Johan Askling
Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers. RMD open 9 (1) (2023)
Bénédicte Delcoigne, Tine Iskov Kopp, Elizabeth V Arkema, Karin Hellgren, Sella Aarrestad Provan, Heikki Relas, Kalle Aaltonen, Nina Trokovic, Bjorn Gudbjornsson, Gerdur Grondal, Eirik Klami Kristianslund, Jesper Lindhardsen, Lene Dreyer, Johan Askling
Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers. RMD open 9 (1) (2023)
Thomas Frisell, Hannah Bower, Matilda Morin, Eva Baecklund, Daniela Di Giuseppe, Bénédicte Delcoigne, Nils Feltelius, Helena Forsblad-d'Elia, Elisabet Lindqvist, Ulf Lindström, Johan Askling, null null
Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme. Annals of the rheumatic diseases (2023)
Bénédicte Delcoigne, Tine Iskov Kopp, Elizabeth V Arkema, Karin Hellgren, Sella Aarrestad Provan, Heikki Relas, Kalle Aaltonen, Nina Trokovic, Bjorn Gudbjornsson, Gerdur Grondal, Eirik Klami Kristianslund, Jesper Lindhardsen, Lene Dreyer, Johan Askling
Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers. RMD open 9 (1) (2023)
Liselotte Tidblad, Helga Westerlind, Bénédicte Delcoigne, Johan Askling, Saedis Saevarsdottir
Comorbidities and chance of remission in patients with early rheumatoid arthritis receiving methotrexate as first-line therapy: a Swedish observational nationwide study. RMD open 9 (4) (2023)
Bénédicte Delcoigne, AnnaCarin Horne, Johan Reutfors, Johan Askling
Risk of Psychiatric Disorders in Juvenile Idiopathic Arthritis: Population- and Sibling-Controlled Cohort and Cross-Sectional Analyses. ACR open rheumatology 5 (5) (2023)
Bénédicte Delcoigne, AnnaCarin Horne, Johan Reutfors, Johan Askling
Risk of Psychiatric Disorders in Juvenile Idiopathic Arthritis: Population- and Sibling-Controlled Cohort and Cross-Sectional Analyses. ACR open rheumatology (2023)
Liselotte Tidblad, Helga Westerlind, Bénédicte Delcoigne, Johan Askling, Saedis Saevarsdottir
Comorbidities and chance of remission in patients with early rheumatoid arthritis receiving methotrexate as first-line therapy: a Swedish observational nationwide study. RMD open 9 (4) (2023)
Bénédicte Delcoigne, Tine Iskov Kopp, Elizabeth V Arkema, Karin Hellgren, Sella Aarrestad Provan, Heikki Relas, Kalle Aaltonen, Nina Trokovic, Bjorn Gudbjornsson, Gerdur Grondal, Eirik Klami Kristianslund, Jesper Lindhardsen, Lene Dreyer, Johan Askling
Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers. RMD open 9 (1) (2023)
Bénédicte Delcoigne, AnnaCarin Horne, Johan Reutfors, Johan Askling
Risk of Psychiatric Disorders in Juvenile Idiopathic Arthritis: Population- and Sibling-Controlled Cohort and Cross-Sectional Analyses. ACR open rheumatology 5 (5) (2023)
Liselotte Tidblad, Helga Westerlind, Bénédicte Delcoigne, Johan Askling, Saedis Saevarsdottir
Comorbidities and chance of remission in patients with early rheumatoid arthritis receiving methotrexate as first-line therapy: a Swedish observational nationwide study. RMD open 9 (4) (2023)
Hannah Bower, Thomas Frisell, Daniela di Giuseppe, Bénédicte Delcoigne, Ulf Lindström, Carl Turesson, Katerina Chatzidionysiou, Elisabet Lindqvist, Ann Knight, Helena Forsblad-d'Elia, Johan Askling
Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden. RMD open 9 (4) (2023)
Hannah Bower, Thomas Frisell, Daniela di Giuseppe, Bénédicte Delcoigne, Ulf Lindström, Carl Turesson, Katerina Chatzidionysiou, Elisabet Lindqvist, Ann Knight, Helena Forsblad-d'Elia, Johan Askling
Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden. RMD open 9 (4) (2023)
Hannah Bower, Thomas Frisell, Daniela di Giuseppe, Bénédicte Delcoigne, Ulf Lindström, Carl Turesson, Katerina Chatzidionysiou, Elisabet Lindqvist, Ann Knight, Helena Forsblad-d'Elia, Johan Askling
Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden. RMD open 9 (4) (2023)
Liselotte Tidblad, Helga Westerlind, Bénédicte Delcoigne, Johan Askling, Saedis Saevarsdottir
Comorbidities and treatment patterns in early rheumatoid arthritis: a nationwide Swedish study. RMD open 8 (2) (2022)
Rene Lindholm Cordtz, Johan Askling, Bénédicte Delcoigne, Karin E Smedby, Eva Baecklund, Christine Ballegaard, Pia Isomäki, Kalle Aaltonen, Bjorn Gudbjornsson, Thorvardur Jon Love, Sella Aarrestad Provan, Brigitte Michelsen, Joseph Sexton, Lene Dreyer, Karin Hellgren
Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study. RMD open 8 (2) (2022)
Bénédicte Delcoigne, Lotta Ljung, Sella A Provan, Bente Glintborg, Merete Lund Hetland, Kathrine Lederballe Grøn, Ritva Peltomaa, Heikki Relas, Carl Turesson, Bjorn Gudbjornsson, Brigitte Michelsen, Johan Askling
Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs: results from four Nordic countries. Annals of the rheumatic diseases 81 (6) (2022)
Rene Lindholm Cordtz, Johan Askling, Bénédicte Delcoigne, Karin E Smedby, Eva Baecklund, Christine Ballegaard, Pia Isomäki, Kalle Aaltonen, Bjorn Gudbjornsson, Thorvardur Jon Love, Sella Aarrestad Provan, Brigitte Michelsen, Joseph Sexton, Lene Dreyer, Karin Hellgren
Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study. RMD open 8 (2) (2022)
Liselotte Tidblad, Helga Westerlind, Bénédicte Delcoigne, Johan Askling, Saedis Saevarsdottir
Comorbidities and treatment patterns in early rheumatoid arthritis: a nationwide Swedish study. RMD open 8 (2) (2022)
Daniela di Giuseppe, Ulf Lindström, Hannah Bower, Bénédicte Delcoigne, Thomas Frisell, Katerina Chatzidionysiou, Christopher Sjöwall, Elisabet Lindqvist, Johan Askling
Comparison of treatment retention of originator vs biosimilar products in clinical rheumatology practice in Sweden. Rheumatology (Oxford, England) 61 (9) (2022)
Liselotte Tidblad, Helga Westerlind, Bénédicte Delcoigne, Johan Askling, Saedis Saevarsdottir
Comorbidities and treatment patterns in early rheumatoid arthritis: a nationwide Swedish study. RMD open 8 (2) (2022)
Viktor Molander, Hannah Bower, Thomas Frisell, Bénédicte Delcoigne, Daniela Di Giuseppe, Johan Askling, null null
Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritis. Annals of the rheumatic diseases (2022)
Michael John Nissen, Bénédicte Delcoigne, Daniela di Giuseppe, Lennart T H Jacobsson, Merete Lund Hetland, Adrian Ciurea, Lucie Nekvindova, Florenzo Iannone, Nurullah Akkoc, Tuulikki Sokka-Isler, Karen Minde Fagerli, Maria Jose Santos, Catalin Codreanu, Manuel Pombo-Suarez, Ziga Rotar, Bjorn Gudbjornsson, Irene van der Horst-Bruinsma, Anne Gitte Loft, Burkhard Möller, Herman Mann, Fabrizio Conti, Gozde Yildirim Cetin, Heikki Relas, Brigitte Michelsen, Pedro Avila Ribeiro, Ruxandra Ionescu, Carlos Sanchez-Piedra, Matija Tomsic, Árni Jón Geirsson, Johan Askling, Bente Glintborg, Ulf Lindström
The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis. Rheumatology (Oxford, England) 61 (12) (2022)
Rene Lindholm Cordtz, Johan Askling, Bénédicte Delcoigne, Karin E Smedby, Eva Baecklund, Christine Ballegaard, Pia Isomäki, Kalle Aaltonen, Bjorn Gudbjornsson, Thorvardur Jon Love, Sella Aarrestad Provan, Brigitte Michelsen, Joseph Sexton, Lene Dreyer, Karin Hellgren
Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study. RMD open 8 (2) (2022)
Bénédicte Delcoigne, Sella Aarrestad Provan, Hilde Berner Hammer, Daniela di Giuseppe, Thomas Frisell, Bente Glintborg, Gerdur Grondal, Bjorn Gudbjornsson, Merete Lund Hetland, Brigitte Michelsen, Dan Nordström, Heikki Relas, Johan Askling
Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration. Rheumatology (Oxford, England) 61 (11) (2022)
Helga Westerlind, Bénédicte Delcoigne, Johan Askling
Siblings of patients with rheumatoid arthritis have an increased mortality rate: a Swedish cohort study. RMD open 6 (1) (2021)
Bénédicte Delcoigne, Ali Manouchehrinia, Christian Barro, Pascal Benkert, Zuzanna Michalak, Ludwig Kappos, David Leppert, Jon A Tsai, Tatiana Plavina, Bernd C Kieseier, Jan Lycke, Lars Alfredsson, Ingrid Kockum, Jens Kuhle, Tomas Olsson, Fredrik Piehl
Blood neurofilament light levels segregate treatment effects in multiple sclerosis. Neurology 94 (11) (2020)

Bénédicte Delcoigne.css-eqlu8i{font-size:small;padding-left:4px;} (Benedicte Delcoigne)

Publication Activity (10 Years)

Top Topics

Top Venues

Bénédicte Delcoigne (Benedicte Delcoigne)